MDL | - |
---|---|
Molecular Weight | 351.36 |
Molecular Formula | C15H21N5O5 |
SMILES | OC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C2N=CN=C3N[C@@H]4[C@@H](O)CCC4)O1)O)O |
Ki: 3.1 nM (Adenosine A1 receptor) and 1300 nM (Adenosine A2 receptor) [1]
GR79236 decreases locomotor activity and inhibits DMCM-induced seizures in mice (ED
50
s of 0.13 mg/kg and 0.3 mg/kg, respectively)
[1]
.
Oral administration of GR79236 (0.1-10 mg/kg) to fed rats induces minimal changes in the plasma concentration of non-esterified fatty acids and in the blood concentrations of glucose and lactate
[3]
.
Intravenous infusion of GR79236 to fasted pithed rats, or oral administration of GR79236 to fasted conscious rats and dogs, produces time- and dose-dependent decreases in the plasma non-esterified fatty acid concentration. In the fasted rats, doses of GR79236 that lowered plasma levels of non-esterified fatty acids also produced hypotriglyceridaemia and anti-ketotic effects
[3]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
H 2 O : 100 mg/mL ( 284.61 mM ; Need ultrasonic)
DMSO : ≥ 100 mg/mL ( 284.61 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.8461 mL | 14.2304 mL | 28.4608 mL |
5 mM | 0.5692 mL | 2.8461 mL | 5.6922 mL |
10 mM | 0.2846 mL | 1.4230 mL | 2.8461 mL |
Add each solvent one by one: PBS
Solubility: 11.11 mg/mL (31.62 mM); Clear solution; Need ultrasonic and warming and heat to 60°C
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (7.12 mM); Clear solution
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.5 mg/mL (7.12 mM); Clear solution